FDA Committee Unanimously Votes to Approve Tesamorelin (Egrifta) for Lipodystrophy

FDA Committee Unanimously Votes to Approve Tesamorelin (Egrifta) for Lipodystrophy

http://www.hivandhepatitis.com/recent/2010/0604_2010_a.html

http://www.poz.com/articles/egrifta_fda_recommends_761_18484.shtml

Share this post